-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Mereo BioPharma Group plc quarterly/annual Operating Income (Loss) history and growth rate from 2022 to Q3 2025.
- Mereo BioPharma Group plc Operating Income (Loss) for the quarter ending September 30, 2025 was -$10M, a 6.85% decline year-over-year.
- Mereo BioPharma Group plc Operating Income (Loss) for the twelve months ending September 30, 2025 was -$47M, a 19.8% decline year-over-year.
- Mereo BioPharma Group plc annual Operating Income (Loss) for 2024 was -$47.4M, a 66.7% decline from 2023.
- Mereo BioPharma Group plc annual Operating Income (Loss) for 2023 was -$28.4M, a 47.8% increase from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)